Clinical trials recruiting for Rectal Cancer, Adenocarcinoma
4
Recruiting trials
0
US states with sites
6
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 2 3Not applicable 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Capecitabine | 2 |
| Bevacizumab | 1 |
| CRT+PD-1 inhibitor+Probio-M9 | 1 |
| Metronidazole | 1 |
| Oxaliplatin | 1 |
| SCRT | 1 |
| Sintilimab | 1 |
| liposomal irinotecan | 1 |
| trastuzumab deruxtecan (T-DXd) | 1 |
Self-screener
Recruiting trials
- Intestinal Microbiome Modulation With Antibiotics in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer
- Neoadjuvant Chemoradiotherapy Plus Tislelizumab With or Without Probio-M9 in pMMR/MSS Locally Advanced Rectal Cancer
- SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC
- Upfront Trastuzumab-Deruxtecan Plus Capecitabine and Bevacizumab for Patients With HER-2 Positive Metastatic Colorectal Cancer.
Related conditions
Trials recruiting for Rectal Cancer, Adenocarcinoma often also study these conditions. Each links to its own recruiting-trial list.
Colorectal cancer 1359Tislelizumab 4Rectal Adenocarcinoma 23Neoadjuvant Therapy 23Immunotherapy 40Colorectal Adenocarcinoma 23
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Rectal Cancer, Adenocarcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.